- Home
- ALT vs PMO Comparison
ALT vs PMO Comparison
Compare ALT & PMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ALT | PMO |
|---|---|---|
| Founded | 1997 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 415.3M | 279.5M |
| IPO Year | 2005 | N/A |
Fundamental Metrics
Financial Performance| Metric | ALT | PMO |
|---|---|---|
| Price | $3.09 | $10.19 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $17.67 | N/A |
| AVG Volume (30 Days) | ★ 3.2M | 60.9K |
| Earning Date | 03-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.10% |
| EPS Growth | ★ 25.37 | N/A |
| EPS | N/A | ★ 0.42 |
| Revenue | ★ $41,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $23.92 |
| Revenue Growth | ★ 105.00 | N/A |
| 52 Week Low | $2.87 | $9.56 |
| 52 Week High | $7.73 | $10.87 |
Technical Indicators
Market Signals| Indicator | ALT | PMO |
|---|---|---|
| Relative Strength Index (RSI) | 35.47 | 37.92 |
| Support Level | $2.91 | $10.17 |
| Resistance Level | $4.25 | $10.50 |
| Average True Range (ATR) | 0.18 | 0.09 |
| MACD | -0.02 | -0.04 |
| Stochastic Oscillator | 25.56 | 37.07 |
Price Performance
Historical ComparisonAbout ALT Altimmune Inc.
Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.
About PMO Putnam Municipal Opportunities Trust
Putnam Municipal Opportunities Trust is a non-diversified closed-end management investment company. It seeks to provide as high a level of current income free from federal income tax as Putnam Management believes is consistent with the preservation of capital. The fund invests in healthcare, utilities, transportation, tax bonds, local debt, state debt, and education.